Paloma Partners’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Paloma Partners’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,084	Closed	-$113K	–	2474
2021 Q4	$113K	Buy	+13,084	New	+$83.2K	﹤0.01%	1740
2021 Q3	–	Sell	-19,312	Closed	-$128K	–	2113
2021 Q2	$128K	Buy	+19,312	New	+$122K	﹤0.01%	1624

Other funds holding LHDX

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Eclipse Ventures Palo Alto, California $39.6M AUM

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $867M AUM 16.97% 1-Year Est. Return

Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return